Diagnosis and management of acute otitis media in the urgent care setting

Annals of Emergency Medicine

Volumn 39, Issue 4, 2002, Pages 413-421

  McCracken Jr , George H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFIXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; DRUG MEGADOSE; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; HAEMOPHILUS INFLUENZAE; HUMAN; MEDICAL DECISION MAKING; MORAXELLA CATARRHALIS; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0036199372     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2002.122772     Document Type: Article

References (55)

1. Increasing prevalence of recurrent otitis media among children in the United States
2. Office visits for otitis media: United States 1975-1990
3. Direct expenditures related to otitis media diagnoses: Extrapolations from a pediatric Medicaid cohort
4. Persistent acute otitis media: I. Causative pathogens
5. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections
6. Antimicrobial use in febrile children diagnosed with respiratory tract illness in an emergency department
7. Infectious disease issues in the emergency department
8. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study
9. Otitis media with effusion (OME): Highly prevalent and often the forerunner of acute otitis media (AOM during the first year of life [abstract]
10. Trends in antimicrobial drug prescribing among office-based physicians in the United States
11. The problem of resistant bacteria for the management of acute otitis media
12. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media
13. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance study
14. Dtitis externa, otitis media, mastoiditis
15. Prevalence of various respiratory viruses in the middle ear during acute otitis media
16. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: A collaborative study
17. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US Medical Centers in 1992 and 1993
18. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to oral agents: Results of a 1998 US outpatient surveillance study
19. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters
20. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States
21. Resistant pneumococci: Protecting patients through judicious use of antibiotics
22. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms
23. Tympanocentesis to tap or not to tap
24. Acute otitis media: Diagnosis and management in the year 2000
25. The merck manual of diagnosis and therapy
26. Acute otitis media: I. Improving diagnostic accuracy
27. Accurately diagnosing acute otitis media: "dispose of the disposables."
28. Evaluation of the patient with sore throat, earache, and sinusitis: An evidence based approach
29. Review of consensus reports on management of acute otitis media
30. Costs arising from otitis media
31. Signs and symptoms predicting acute otitis media
32. Clinical relapse of acute otitis media (CR-AOM) within 1 month after completion of treatment (Tx): Bacteriologic correlates
33. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae therapeutic working group
34. Otitis media in children
35. Otitis media in 2,253 Pittsburgh-area infants: Prevalence and risk factors during the first two years of life
36. The heritability of otitis media: A twin and triplet study
37. Epidemiology of otitis media onset by six months of age
38. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children
39. Nasopharyngeal colonization with pathogens causing otitis media: How does this information help us?
40. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
41. Fundamental basis for rational therapeutics in acute otitis media
42. Penetration of ceftriaxone into the middle ear fluid of children
43. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media
44. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children
45. Safety and tolerability of a new formulation (90 mg/kg/d divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae
46. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media
47. Bacteriological and clinical efficacy of a new amoxicillin/clavulanate extra strength formulation (A/C 14:1) in the treatment of acute otitis media (AOM)
48. Prospective study of antibiotic prescribing for children
49. Efficacy of fixed combination antibiotics versus separate components in otitis media
50. Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media
51. Clinical efficacy of antimicrobial drugs for acute otitis media: Metaanalysis of 5,400 children from thirty-three randomized trials
52. Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance of penicillin in cases of acute otitis media
53. Rx product listings
54. Efficacy of a heptavalent pneumococcal conjugate vaccine (PncCRM) against serotype-specific, culture-confirmed pneumococcal acute otitis media in infants and children